Several of the CTAg genes detected in the CoMMpass analysis (MAGEA3, A6, A12, and CSAG1) were also in the CTAg gene set associated with resistance to anti-CTLA-4 therapy in melanoma [7]. The gene discussed is MAGEA3; the disease is melanoma.